Home
/ Actylis
/ Competitors

Actylis Competitors and Similar CompaniesClear all

Actylis's competitors and similar companies include Yungjin Pharm, Sagittarius Life Science, Llorens Pharmaceutical and A&Z Pharmaceutical.

	Actylis Aceto Corporation sources, markets, sells, and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products, and specialty chemicals.	Yungjin Pharm Yungjin Pharm is a company that develops and distributes pharmaceutical products.	Sagittarius Life Science Sagittarius Life Science (佰研生化科技股份有限公司) is a biotechnology company that researches and develops botanical drug products.	Llorens Pharmaceutical Llorens Pharmaceutical is a pharmaceutical company.	A&Z Pharmaceutical A&Z Pharmaceutical is a company that develops, manufactures, and markets pharmaceutical products and nutritional supplements.
Founding Date	Founding Date 1947	Founding Date 1952	Founding Date 1998	Founding Date 1985	Founding Date 1995
Type	Type Public	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare Manufacturing & Industrial agritech biotech chemicals distribution drug development nutrition pharma supplements	Tags Healthcare biotech cosmetics drug development nutrition pharma supplements	Tags Healthcare biotech drug development nutrition pharma supplements	Tags Healthcare distribution drug development nutrition pharma supplements	Tags Healthcare biotech drug development nutrition pharma supplements
Locations	Locations Port Washington, US HQ Lyon, FR Paris, FR Düsseldorf, DE Hamburg, DE Hamburg, DE see more	Locations HQ	Locations HQ	Locations Miami, US HQ	Locations Hauppauge, US HQ
Employees	Employees 315	Employees 574	Employees N/A	Employees 22	Employees 481
Financial
Revenue (est.)	Revenue (est.) $711.4m (FY, 2018)	Revenue (est.) ₩252b (FY, 2024)	Revenue (est.) NT$467.8m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $599.8m (FY, 2018)	Cost of goods ₩164.2b (FY, 2024)	Cost of goods NT$371.9m (FY, 2024)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $111.6m (FY, 2018)	Gross profit ₩90.5b (FY, 2024)	Gross profit NT$98.6m (FY, 2024)	Gross profit N/A	Gross profit N/A
Net income	Net income ($316.1m) (FY, 2018)	Net income ₩1.2b (FY, 2024)	Net income (NT$49.7m) (FY, 2024)	Net income N/A	Net income N/A